Pharmaceutical Technology on MSN
Supernus and Indivior merge to create scaled, CNS-focused entity
Through this merger, the duo will combine their commercial medicinal portfolios, which span CNS and opioid use disorders (OUDs).
Tech Times on MSN
Deep brain stimulation activates hidden astrocyte gene programs in human tissue study
Deep brain stimulation researchers at UCLA and UT Southwestern published a Nature study mapping, for the first time in living ...
Combines highly complementary businesses, with a diversified portfolio of CNS medicines totaling approximately $2.2 billion in combined annual revenues Enhanced financial position and free cash flow ...
Hartlepool Mail on MSN
Thousands raised to give courageous Hartlepool teenager who defied the odds a fitting send off
Thousands of pounds has been raised to give a courageous Hartlepool teenager a fitting send off after she died just weeks ...
The Gazette on MSN
Children's book launched to raise funds for a young boy with disabilites
A children’s book is helping raise funds for a young boy who needs specialist therapies.
Total revenues were $219.1 million in the second quarter 2026, a 32% increase compared to same period last year. Regulatory submission to the FDA for second supplier for ONAPGO remains on-track for ...
As Noah’s Ark Children's Hospice celebrates 20 years of helping young people like Sophie Charles, it faces a £1 million ...
Switching off one copy of a gene also enabled one of the children to walk independently for the first time. A tailored treatment has reduced seizures and improved developmental skills in two boys with ...
Functional neurological disorder (FND) is a common and disabling condition with diverse presentations, such as motor (weakness, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results